Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

腹膜透析液(乳酸盐-G4.25%) - NMPA Drug Approval Details

Approvals/NMPA/Peritoneal Dialysis Solution(Lactate-G4.25%)

Approved

化学药品

Peritoneal Dialysis Solution(Lactate-G4.25%)

宁波天益药业科技有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 8, 2026
Approval ID: 8nsvvhVLspB
Company: 宁波天益药业科技有限公司
Type: 化学药品

Approval Details

Approval Id: 8nsvvhVLspB
Approval Number: 国药准字H20265888
Generic Name: 腹膜透析液(乳酸盐-G4.25%)
Generic Name En: Peritoneal Dialysis Solution(Lactate-G4.25%)
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 含4.25%葡萄糖（5000ml/袋）
Reg Date: 2026-09-08
Company Name: 宁波天益药业科技有限公司
Company Address: 浙江省宁波高新区菁华路1100号全部
Production Company Name: 宁波天益药业科技有限公司
Production Company Address: 宁波市鄞州区菁华路1100号全部

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 8, 2026

Approval ID

8nsvvhVLspB

Type

化学药品

Back to NMPA Approvals